发明名称 Modified release pharmaceutical compositions
摘要 Disclosed herein are multiparticulate modified release pharmaceutical compositions comprising: (a) a first portion comprising an active ingredient, at least one surfactant and at least one release modifying agent and (b) a second portion comprising an active ingredient and optionally a release modifying agent. Particularly, the active ingredient in the first portion is a calcium channel blocker and the modified release composition is in the form of a multiparticulate tablet.
申请公布号 US8865213(B2) 申请公布日期 2014.10.21
申请号 US201012981077 申请日期 2010.12.29
申请人 USV Limited;Indicus Pharma LLC 发明人 Sheth Nitin Vadilal;Jog Sunil Suresh;Chothe Santosh Sadashiv;Tupe Sampada Hemant
分类号 A61K9/26;A61K9/14;A61K9/50;A61K31/4422;A61K9/20 主分类号 A61K9/26
代理机构 Schwegman Lundberg & Woessner , P.A. 代理人 Schwegman Lundberg & Woessner , P.A.
主权项 1. A multiparticulate modified release pharmaceutical composition comprising: a first portion comprising at least one active ingredient comprising a calcium channel blocker,at least one surfactant, andat least one release modifying agent; and a second portion mixed with the first portion, the second portion comprising at least one active ingredient comprising a calcium channel blocker, andoptionally, at least one release modifying agent,the second portion having a different release profile than the first portion; the first portion having a form comprising a plurality of at least one selected from pellets, granules, microparticles, nanoparticles, and a combination thereof, the second portion having a form comprising a plurality of matrix granules, wherein the active ingredient of the first portion is released at pH above about 5.5, and release of the active ingredient of the second portion is pH independent.
地址 IN